Clinical Trial Update: Research Study Using Recombinant Human Insulin-Like Growth Factor-1/Recombinant Human Insulin-Like Growth Factor Binding Protein-3 for Children With Noonan Syndrome [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating a combination of recombinant human insulin-like growth factor-1 and recombinant human insulin-like growth factor binding protein-3 fo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Noonan Syndrome

Drugs mentioned

• Recombinant human insulin-like growth factor-1 / recombinant human insulin-like growth factor binding protein-3 (IGF-1/IGFBP-3)

Snippet

Sponsor: Insmed Incorporated | Conditions: Noonan Syndrome | Phase 2 | Status: TERMINATED